Offer - Urjas Oil for just ₹ 1 X
Vigoquin KT Eye Drop is an allopathic medicine The correct dosage of Vigoquin KT Eye Drop depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Vigoquin KT Eye Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Vigoquin KT Eye Drop safe for pregnant women?
Vigoquin KT Eye Drop may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Vigoquin KT Eye Drop again without your doctor's advice.
Is the use of Vigoquin KT Eye Drop safe during breastfeeding?
Vigoquin KT Eye Drop may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Vigoquin KT Eye Drop on the Kidneys?
Vigoquin KT Eye Drop does not damage the kidneys.
What is the effect of Vigoquin KT Eye Drop on the Liver?
Vigoquin KT Eye Drop does not damage the liver.
What is the effect of Vigoquin KT Eye Drop on the Heart?
Vigoquin KT Eye Drop is rarely harmful for the heart.
Vigoquin KT Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Vigoquin KT Eye Drop unless your doctor advises you to do so -
Is this Vigoquin KT Eye Drop habit forming or addictive?
No, there is no any evidence that Vigoquin KT Eye Drop is addictive.
Interaction between Food and Vigoquin KT Eye Drop
Vigoquin KT Eye Drop may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Vigoquin KT Eye Drop
Side effects of drinking alcohol and taking Vigoquin KT Eye Drop at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
Rarely, one can develop an allergic reaction to Vigoquin KT Eye Drop. One might feel short of breath and might find it difficult to speak, one might develop a rash or an itch and swell on the lips, face, and throat. If you suffer from any of these symptoms, inform your doctor immediately.
Vigoquin KT Eye Drop is available as an injection and as a tablet. Your doctor may give you the intravenous or intramuscular injection of Vigoquin KT Eye Dropdepends on the severity of disease and patient condition. Tablet is to be taken by the oral route. It is important to take the tablet at the same time every day so that you do not forget the dose. Take the tablet with food or an antacid to prevent or lessen stomach upset. Please follow the instructions of your doctor completely while taking Vigoquin KT Eye Drop.
No, Vigoquin KT Eye Drop doesn't cause anxiety. Anxiety is a group of mental disorder characterized by excessive fear and feels nervousness. It has not been reported by the patients who are taking it. However, if you experience anxiety after taking this drug then it might be due to some other medical condition. You are advised to discuss it with your doctor.
Vigoquin KT Eye Drop is a potent, short-acting non-steroidal anti-inflammatory drug. It is extremely important that you follow the instructions of your doctor completely and do not take any extra doses or take it for a longer period of time as that might result in some side effects.
Yes, Vigoquin KT Eye Drop is associated with a risk of bleeding. Since Vigoquin KT Eye Drop inhibits platelet function, it should not be used in people with confirmed or suspected cardiovascular bleeding and in patients with high risk of bleeding.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)